Etoposide and malignant neoplasm progression Patient Reports February 12, 2012

Etoposide Side Effects Report #5660507-6
Etoposide side effect was reported by a Physician from TURKEY on Feb 27, 2008. Male patient, 17 years of age, was diagnosed with testicular neoplasm and was treated with Etoposide. After drug was administered, patient experienced the following side effects: haemorrhagic cerebral infarction, malignant neoplasm progression. Etoposide dosage: 180 MG, DAILY X 4 CYCLES. During the same period patient was treated with CISPLATIN, BLEOMYCIN SULPHATE. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5081712-6
Etoposide side effect was reported by a Health Professional from UNITED STATES on July 12, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with Etoposide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Etoposide dosage: unknown. Patient died.

Etoposide Side Effects Report #5072233-5
Etoposide side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Female patient, 48 years of age, was diagnosed with metastatic neoplasm and was treated with Etoposide. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Etoposide dosage: unknown. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient died on 05/31/2006.

Etoposide Side Effects Report #6109465-0
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2009. Male patient, weighting 174.2 lb, was diagnosed with glioblastoma multiforme and was treated with Etoposide. After drug was administered, patient experienced the following side effects: glioblastoma multiforme, malignant neoplasm progression, treatment failure. Etoposide dosage: 100MG DAILY X 21 DAYS PO. During the same period patient was treated with BEVACIZUMAB, PRILOSEC, DILANTIN, DEXAMETHASONE, TYLENOL. Patient died on 02/15/2009.


Etoposide Side Effects Report #5705411-X
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 6 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Etoposide. After drug was administered, patient experienced the following side effects: graft versus host disease, malignant neoplasm progression. Etoposide dosage: unknown. Patient died.

Etoposide Side Effects Report #5703962-5
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, 14 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Etoposide. After drug was administered, patient experienced the following side effects: graft versus host disease, malignant neoplasm progression. Etoposide dosage: unknown. During the same period patient was treated with THYMOGLOBULIN. Patient died.

Etoposide Side Effects Report #5705384-X
Etoposide side effect was reported by a Health Professional from GERMANY on Apr 09, 2008. Female patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with Etoposide. After drug was administered, patient experienced the following side effects: encephalitis cytomegalovirus, graft versus host disease, malignant neoplasm progression. Etoposide dosage: unknown. During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient died.

Etoposide Side Effects Report #4557685-9
Etoposide side effect was reported by a Consumer or non-health professional from on Dec 03, 2003. Male patient, 82 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Etoposide. After drug was administered, patient experienced the following side effects: anaphylactoid reaction, bronchospasm, cardiac failure congestive, malignant neoplasm progression, swelling face, urticaria, wheezing. Etoposide dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE, CYCLOPHOSPHAMIDE, MORPHINE, FENTANYL, DEXAMETHASONE, ROFECOXIB. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5961292-0
Etoposide side effect was reported by a Health Professional from SLOVAKIA (Slovak Republic) on Nov 18, 2008. Male patient, 70 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: leukopenia, malignant neoplasm progression, paraneoplastic syndrome, thrombocytopenia. Etoposide dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient died.


Etoposide Side Effects Report #5541536-X
Etoposide side effect was reported by a Health Professional from TURKEY on Dec 07, 2007. Male patient, 61 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: leukocytoclastic vasculitis, malignant neoplasm progression. Etoposide dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Etoposide Side Effects Report #5148056-5
Etoposide side effect was reported by a Consumer or non-health professional from AUSTRALIA on Nov 08, 2006. Female patient, 14 years of age, was diagnosed with ovarian cancer and was treated with Etoposide. After drug was administered, patient experienced the following side effects: deafness neurosensory, malignant neoplasm progression, nephropathy toxic, neurotoxicity, ototoxicity, peripheral sensory neuropathy, renal failure, renal tubular necrosis. Etoposide dosage: unknown. During the same period patient was treated with CISPLATIN, ETHYOL. Patient died.

Etoposide Side Effects Report #5292193-1
Etoposide side effect was reported by a Health Professional from POLAND on Apr 06, 2007. Female patient was treated with Etoposide. After drug was administered, patient experienced the following side effects: anaemia, arrhythmia , cardiac failure, dysphagia, leukopenia, malignant neoplasm progression, nausea , pulmonary haemorrhage. Etoposide dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.